Holen Sie sich die Stockscreener-App
0.2331
8.66%
-0.0221
Handel nachbörslich:
.24
0.0069
+2.96%
Bioaffinity Technologies Inc Aktie (BIAF) Neueste Nachrichten
Can bioAffinity Technologies Inc. be recession proof2025 Market Overview & Daily Technical Stock Forecast Reports - sundaytimes.kr
bioAffinity 2025 Q2 Earnings Continued Losses Despite Operational Optimism - AInvest
bioAffinity Technologies Sees Surge in CyPath® Lung Test Sales - MSN
bioAffinity Technologies Announces Closing of Private Placement and Warrant Inducement Transaction for Approximately $1.2 Million in Gross Proceeds - BioSpace
bioAffinity Technologies Reports Strong Growth in Lung Test Sales - TipRanks
bioAffinity Misses Q2 Revenue Target - AOL.com
bioAffinity Technologies Secures $1.2M Through Private Placement - TipRanks
bioAffinity Technologies, Inc. SEC 10-Q Report - TradingView
bioAffinity Technologies earnings missed by $0.07, revenue topped estimates - Investing.com Canada
bioAffinity Technologies Reports Second Quarter 2025 Results - Bluefield Daily Telegraph
Published on: 2025-08-14 05:42:08 - Newser
What recovery options are there for bioAffinity Technologies Inc. Equity WarrantTake Profit & Risk Controlled Daily Trade Plans - Newser
bioAffinity Technologies Announces Pricing of Private Placement and Warrant Inducement Transaction for Approximately $1.2 Million in Gross Proceeds - BioSpace
bioAffinity Technologies announces pricing of private placement - MSN
Custom watchlist performance reports with bioAffinity Technologies Inc. Equity WarrantMarket Sentiment Report & Consistent Income Trade Recommendations - Newser
Combining machine learning predictions for bioAffinity Technologies Inc.Quarterly Performance Summary & Risk Managed Trade Strategies - Newser
BioAffinity Technologies Raises $1.2 Million in Private Placement - MarketScreener
bioAffinity Technologies raises $1.2 million in private placement - Investing.com
bioAffinity Secures Fresh Capital as Investors Back Early-Stage Cancer Detection Technology - Stock Titan
RBC Global Asset Management Inc. announces final details on maturity of RBC Target 2025 Canadian Government Bond ETF, RBC Target 2025 Canadian Corporate Bond Index ETF and RBC Target 2025 U.S. Corporate Bond ETF - The Globe and Mail
Navigating Dilution and Growth: bioAffinity Technologies' Warrant Strategy in the Biotech Landscape - AInvest
Early Cancer Detection Biotech Secures $1.2M Funding to Advance Noninvasive Testing Technology - Stock Titan
BioAffinity Technologies Announces $1.2M Capital Raise Through Private Placement Of 990 Series B Preferred Shares Convertible Into 4.3M Common Shares At $0.23/Share And 6.7M Warrants At $0.352/Share, Plus $253K Warrant Inducement For Immediat - 富途牛牛
D-Wave Quantum vs. IonQ: Which is the Better Quantum Computing Stock? - The Globe and Mail
4 Reasons to Buy PayPal Stock Like There's No Tomorrow - The Globe and Mail
Volume spikes in bioAffinity Technologies Inc. stock – what they meanJobs Report & Free Technical Pattern Based Buy Signals - Newser
Advanced analytics toolkit walkthrough for bioAffinity Technologies Inc.Free Capital Protection Trading Strategies - Newser
AMD Paves Path for Market Share Gains: Stock Rally Has Just Begun - The Globe and Mail
What’s next for bioAffinity Technologies Inc. Equity Warrant stock priceFree Weekly Return Pick Forecast Reports - Newser
bioAffinity Technologies (BIAF) Expected to Announce Quarterly Earnings on Wednesday - Defense World
Can bioAffinity Technologies Inc. Equity Warrant maintain its current growth rateLow Price High Return Opportunities - mustnews.co.kr
Why bioAffinity Technologies Inc. Equity Warrant stock attracts strong analyst attentionRetirement Investment Outlook and Return Summary - Newser
The Smartest Growth Stock to Buy With $1,000 Right Now - The Globe and Mail
Veradigm Inc. Delays Q2 2025 Financial Report - The Globe and Mail
Akamai Q2 Earnings Surpass Estimates, Revenues Increase Y/Y - The Globe and Mail
Published on: 2025-08-08 17:01:07 - beatles.ru
BIG ROCK BREWERY INC. ANNOUNCES SECOND QUARTER 2025 RESULTS AND A 45% INCREASE IN SECOND QUARTER SALES VOLUMES - The Globe and Mail
Cassava Sciences Appoints Dr. Joseph Hulihan as Chief Medical Officer - The Globe and Mail
Why bioAffinity Technologies Inc. stock is on top investor watchlistsPattern Recognition Tool for ROI Investors - Newser
First Advantage Reduces Interest Rates on Credit Facilities - The Globe and Mail
Published on: 2025-08-04 09:31:00 - beatles.ru
What are bioAffinity Technologies Inc. Equity Warrant company’s key revenue driversGet high-impact stock recommendations now - Jammu Links News
How strong is bioAffinity Technologies Inc. Equity Warrant company’s balance sheetMarket-crushing profits - Jammu Links News
What is the dividend policy of bioAffinity Technologies Inc. Equity Warrant stockCapitalize on strategic market trends - Jammu Links News
Is bioAffinity Technologies Inc. Equity Warrant a growth stock or a value stockAchieve rapid wealth accumulation through smart investing - Jammu Links News
bioAffinity Technologies Inc. Stock Analysis and ForecastAchieve rapid financial growth with expert picks - Jammu Links News
Is bioAffinity Technologies Inc. Equity Warrant stock overvalued or undervaluedFree Market Dynamics Reports - Jammu Links News
How volatile is bioAffinity Technologies Inc. stock compared to the marketFree Market Dynamics Reports - Jammu Links News
What analysts say about bioAffinity Technologies Inc. stockFree Predictions - Jammu Links News
What makes bioAffinity Technologies Inc. stock price move sharplyUnlock powerful insights from market experts - Jammu Links News
What catalysts could drive bioAffinity Technologies Inc. Equity Warrant stock higher in 2025Tremendous growth opportunities - Jammu Links News
Published on: 2025-08-03 18:51:54 - Jammu Links News
How does bioAffinity Technologies Inc. Equity Warrant compare to its industry peersBuild a winning investment strategy - Jammu Links News
What are bioAffinity Technologies Inc. company’s key revenue driversPhenomenal capital appreciation - Jammu Links News
Should I hold or sell bioAffinity Technologies Inc. Equity Warrant stock in 2025Achieve breakthrough investment performance - Jammu Links News
Why is bioAffinity Technologies Inc. Equity Warrant stock attracting strong analyst attentionUnprecedented profits - Jammu Links News
What are the latest earnings results for bioAffinity Technologies Inc.Discover the fastest growing stocks today - Jammu Links News
What are the latest earnings results for bioAffinity Technologies Inc. Equity WarrantNavigate market shifts with confidence - Jammu Links News
What is the dividend policy of bioAffinity Technologies Inc. stockLightning-fast growth - Jammu Links News
Is bioAffinity Technologies Inc. Equity Warrant a good long term investmentMarket-crushing profits - Jammu Links News
Why is bioAffinity Technologies Inc. stock attracting strong analyst attentionCapitalize on emerging trends for profits - Jammu Links News
0.67%
0.75%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):